Friday 6 November 2026
Export IRMD’s income statement to Excel — free account
iRadimed Corporation
IRMD Healthcare Medical Devices
iRadimed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $83.8 million, up 14.4% from fiscal 2024.
- Revenue
- +14.2%
- EPS
- +15.9%
- Free cash flow
- +18.6%
Quarter to September 2026, against a year earlier
86.17
0.63
+0.74%
Follow IRMD
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 5 | 6 |
| 24.78% | 25.04% | 23.52% | 23.42% | ||
| 21.71% | 21.85% | 20.82% | 20.34% | ||
ROIC |
37.60% | 41.46% | 40.36% | 41.79% | |
Return on Tangible Assets |
23.69% | 23.96% | 22.65% | 22.51% | |
Average Days of Receivables |
59.52 | 56.75 | 55.77 | 55.87 | |
Free Cash Flow per Share |
1.30 | 1.88 | 1.92 | 2.00 | |
Free Cash Flow |
16.53 | 23.97 | 24.55 | 25.61 | |
Capital Expenditures |
(8.42) | (4.97) | (2.59) | (1.54) | |
| Other line items | |||||
Cash ROIC |
11.34% | 15.48% | 15.26% | 15.09% | |
Accounts Receivable Turnover |
6.92 | 6.61 | 7.16 | 6.49 | |
Accounts Payable Turnover |
10.49 | 8.38 | 11.11 | 9.21 | |
Inventory Turnover |
1.77 | 1.78 | 1.78 | 1.73 | |
Average Days of Payables |
34.08 | 39.85 | 32.39 | 40.36 | |
Days of Inventory on Hand |
217.61 | 217.01 | 214.68 | 225.01 | |
Tax Rate |
(0.21) | (0.22) | (0.22) | (0.23) | |
Research and Development Expense of Revenue |
3.55% | 3.83% | 3.58% | 3.68% | |
Selling, General and Administrative Expense of Revenue |
42.00% | 40.61% | 40.37% | 39.53% | |
Share Based Compensation of Revenue |
3.48% | 3.22% | 3.30% | 3.32% | |
Operating CF/Net income |
1.11 | 1.23 | 1.18 | 1.13 | |
Depreciation/Fixed assets |
0.05 | 0.06 | 0.07 | 0.07 | |
Capex/Depreciation |
(7.22) | (3.48) | (1.59) | (0.93) | |
Revenue per Share |
6.59 | 6.75 | 6.75 | 6.99 | |
Operating CF per Share |
1.96 | 2.26 | 2.12 | 2.12 | |
Capex per Share |
(0.66) | (0.39) | (0.20) | (0.12) | |
Capex to Sales |
0.10 | 0.06 | 0.03 | 0.02 |
Columns are period end dates · fundamentals updated 6 Nov 2026